Johnson & Johnson
JNJ
NYSE
$178.08
$1.230.70%
Volume5,516,706
05/16/2022 4:00PM Eastern
Quotes delayed
| 04/03/2022 | 01/02/2022 | 10/03/2021 | 07/04/2021 | 04/04/2021 | |
|---|---|---|---|---|---|
| Revenue | 23.43B | 24.80B | 23.34B | 23.31B | 22.32B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 23.43B | 24.80B | 23.34B | 23.31B | 22.32B |
| Cost of Revenue | 7.58B | 7.92B | 7.23B | 7.57B | 7.04B |
| Gross Profit | 15.84B | 16.88B | 16.11B | 15.75B | 15.29B |
| SG&A Expenses | 5.64B | 7.01B | 5.85B | 5.94B | 5.26B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.68B | 19.65B | 16.50B | 16.90B | 15.48B |
| Operating Income | 6.74B | 5.16B | 6.84B | 6.41B | 6.84B |
| Income Before Tax | 5.86B | 4.84B | 3.85B | 6.66B | 7.43B |
| Income Tax Expenses | 713.00M | 100.00M | 182.00M | 384.00M | 1.23B |
| Earnings from Continuing Operations | 5.15B | 4.74B | 3.67B | 6.28B | 6.20B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 5.15B | 4.74B | 3.67B | 6.28B | 6.20B |
| EBIT | 6.74B | 5.16B | 6.84B | 6.41B | 6.84B |
| EBITDA | 8.51B | 7.00B | 8.65B | 8.25B | 8.74B |
| EPS Basic | 1.96 | 1.80 | 1.39 | 2.38 | 2.35 |
| Normalized Basic EPS | 1.64 | 1.06 | 1.63 | 1.56 | 1.65 |
| EPS Diluted | 1.93 | 1.77 | 1.37 | 2.35 | 2.32 |
| Normalized Diluted EPS | 1.62 | 1.05 | 1.61 | 1.54 | 1.63 |
| Average Basic Shares Outstanding | 2.63B | 2.63B | 2.63B | 2.63B | 2.63B |
| Average Diluted Shares Outstanding | 2.67B | 2.67B | 2.67B | 2.67B | 2.67B |
| Dividend Per Share | 1.06 | 1.06 | 1.06 | 1.06 | 1.01 |
| Payout Ratio | 54.13% | 58.93% | 76.11% | 44.46% | 42.91% |
